Clinicians and patients who decide to use targeted therapies in the metastatic setting should understand that treatment-related toxicities may be significant and a detriment to quality of life.
← all excerpts
Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline.
1
—
—